688016 心脉医疗
已收盘 11-22 15:00:00
资讯
新帖
简况
心脉医疗(688016.SH)耗资9998.89万元完成回购0.88%股份
智通财经 · 11-22 21:26
心脉医疗(688016.SH)耗资9998.89万元完成回购0.88%股份
心脉医疗大跌 近期券商看好
智选洞察 · 11-22 14:51
心脉医疗大跌 近期券商看好
华安证券:给予心脉医疗买入评级
证券之星 · 11-21 17:07
华安证券:给予心脉医疗买入评级
心脉医疗:24H2承压明显 看好外海收入增长
华安证券 · 11-21 00:00
心脉医疗:24H2承压明显 看好外海收入增长
心脉医疗11月14日遭主力抛售6658万元 环比增加256.81%
市场透视 · 11-14
心脉医疗11月14日遭主力抛售6658万元 环比增加256.81%
心脉医疗大跌5.01% 4家券商给予增持建议
智选洞察 · 11-14
心脉医疗大跌5.01% 4家券商给予增持建议
心脉医疗11月12日获主力加仓4607万元 环比增加695.68%
市场透视 · 11-12
心脉医疗11月12日获主力加仓4607万元 环比增加695.68%
港股异动 | 微创医疗(00853)盘中涨近8% 心脉医疗前三季度纯利增超42% 小摩上调公司长期净利润率预测
智通财经 · 11-12
港股异动 | 微创医疗(00853)盘中涨近8% 心脉医疗前三季度纯利增超42% 小摩上调公司长期净利润率预测
小摩:予微创医疗“增持”评级 目标价升至7.8港元
智通财经 · 11-11
小摩:予微创医疗“增持”评级 目标价升至7.8港元
XD心脉医11月08日遭主力抛售1458万元 环比增加3213.64%
市场透视 · 11-08
XD心脉医11月08日遭主力抛售1458万元 环比增加3213.64%
心脉医疗:累计回购约89万股
每日经济新闻 · 11-04
心脉医疗:累计回购约89万股
心脉医疗(688016.SH)2024年半年度权益分派:每股派1.66205元 11月7日股权登记
智通财经 · 11-01
心脉医疗(688016.SH)2024年半年度权益分派:每股派1.66205元 11月7日股权登记
心脉医疗:降价压力显现 公司调整2024全年预期
中金公司 · 11-01
心脉医疗:降价压力显现 公司调整2024全年预期
心脉医疗(688016)2024年三季报简析:营收净利润同比双双增长
证券之星 · 10-31
心脉医疗(688016)2024年三季报简析:营收净利润同比双双增长
心脉医疗大跌5.40% 5家券商给予增持建议
智选洞察 · 10-30
心脉医疗大跌5.40% 5家券商给予增持建议
微创医疗(00853.HK)附属心脉医疗科技首九个月赚5.53亿人民币 增长42.5%
阿斯达克财经 · 10-30
微创医疗(00853.HK)附属心脉医疗科技首九个月赚5.53亿人民币 增长42.5%
图解心脉医疗三季报:第三季度单季净利润同比增37.57%
证券之星 · 10-30
图解心脉医疗三季报:第三季度单季净利润同比增37.57%
微创医疗:心脉医疗科技前三季归母净利约5.53亿元,同比增长42.46%
智通财经 · 10-29
微创医疗:心脉医疗科技前三季归母净利约5.53亿元,同比增长42.46%
微创医疗(00853):心脉医疗科技前三季归母净利约5.53亿元,同比增长42.46%
智通财经网 · 10-29
微创医疗(00853):心脉医疗科技前三季归母净利约5.53亿元,同比增长42.46%
心脉医疗10月25日收涨0.93% 主力资金逆市抛售
市场透视 · 10-25
心脉医疗10月25日收涨0.93% 主力资金逆市抛售
加载更多
公司概况
公司名称:
上海微创心脉医疗科技(集团)股份有限公司
所属行业:
专用设备制造业
上市日期:
2019-07-22
主营业务:
上海微创心脉医疗科技(集团)股份有限公司主要从事主动脉及外周血管介入医疗器械的研发、生产和销售。主要产品为胸主动脉覆膜支架系统、腹主动脉覆膜支架系统、术中支架类、球囊类、支架类。公司自成立以来,一直深耕于主动脉及外周血管介入医疗器械领域,通过多年的经验积累,公司已发展成我国主动脉血管介入医疗器械的龙头企业。公司产品已进入全国约1900家医院,主动脉产品国内市场占有率已连续多年排名国产品牌第一。
发行价格:
46.23
{"stockData":{"symbol":"688016","market":"SH","secType":"STK","nameCN":"心脉医疗","latestPrice":102.44,"timestamp":1732258800000,"preClose":108.01,"halted":0,"volume":2776447,"delay":0,"floatShares":123000000,"shares":123000000,"eps":5.3329,"marketStatus":"已收盘","marketStatusCode":5,"change":-5.57,"latestTime":"11-22 15:00:00","open":108.01,"high":108.6,"low":102.44,"amount":291000000,"amplitude":0.057,"askPrice":102.45,"askSize":44,"bidPrice":102.44,"bidSize":33,"shortable":0,"etf":0,"ttmEps":5.3329,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1732498200000},"adr":0,"adjPreClose":108.01,"symbolType":"stock_kcb","openAndCloseTimeList":[[1732239000000,1732246200000],[1732251600000,1732258800000]],"highLimit":118.81,"lowLimit":97.21,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":123262117,"pbRate":3.25,"roa":"--","roe":"14.38%","epsLYR":6.81,"committee":-0.092105,"marketValue":12627000000,"floatMarketCap":12627000000,"peRate":19.209061,"changeRate":-0.0516,"turnoverRate":0.0225,"status":1,"nextConnectDate":"根据港交所公布的数据,今日已停止北向交易,下一个交易日为北京时间 2024-11-25。","afterMarket":{"amount":0,"volume":0,"close":102.44,"buyVolume":400,"sellVolume":0,"time":1732260839464,"indexStatus":"已收盘 11-22 15:30:00","preClose":108.01}},"requestUrl":"/m/hq/s/688016","defaultTab":"news","newsList":[{"id":"2485268418","title":"心脉医疗(688016.SH)耗资9998.89万元完成回购0.88%股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2485268418","media":"智通财经","labels":["Shareholding Changes"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2485268418?lang=zh_cn&edition=full","pubTime":"2024-11-22 21:26","pubTimestamp":1732282000,"startTime":"0","endTime":"0","summary":"智通财经APP讯,心脉医疗(688016.SH)发布公告,截至本公告披露日,公司已完成本次回购。公司以集中竞价交易方式累计回购公司股份108.71万股,占公司总股本的比例为0.88%,回购成交的最高价为78.69元/股,最低价为103.96元/股,回购均价91.98元/股,支付的资金总额为人民币9998.89万元(不含印花税、交易佣金等交易费用)。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1214949.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"Shareholding Changes","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0251","688016"],"gpt_icon":0},{"id":"2485895362","title":"心脉医疗大跌 近期券商看好","url":"https://stock-news.laohu8.com/highlight/detail?id=2485895362","media":"智选洞察","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2485895362?lang=zh_cn&edition=full","pubTime":"2024-11-22 14:51","pubTimestamp":1732258305,"startTime":"0","endTime":"0","summary":"11月22日,心脉医疗股价大幅下跌,截至14点51分,心脉医疗下跌5.01%,报102.60元/股,成交2.76亿元,换手率2.14%,振幅5.56%。资金动向截止发稿,心脉医疗获得主力净流出2949万元,其中超大单流出2666万元,大单流出282万元。主营业务及业绩心脉医疗公司主营业务为主动脉及外周血管介入医疗器械的研发、生产和销售。最新财报显示,今年三季报,心脉医疗实现营业收入9.70亿元,同比增长9.13%,净利润为5.53亿元,同比增长42.46%,基本每股收益为4.49元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241122145248a24d31fb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241122145248a24d31fb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0251","688016"],"gpt_icon":0},{"id":"2485523174","title":"华安证券:给予心脉医疗买入评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2485523174","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2485523174?lang=zh_cn&edition=full","pubTime":"2024-11-21 17:07","pubTimestamp":1732180020,"startTime":"0","endTime":"0","summary":"华安证券股份有限公司谭国超,李婵近期对心脉医疗进行研究并发布了研究报告《24H2承压明显,看好海外收入增长》,本报告对心脉医疗给出买入评级,当前股价为108.01元。公司为国内血管介入器械的领军企业,维持“买入”评级。最新盈利预测明细如下:该股最近90天内共有14家机构给出评级,买入评级9家,增持评级5家;过去90天内机构目标均价为152.69。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024112100027014.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688016","600909"],"gpt_icon":0},{"id":"2485045515","title":"心脉医疗:24H2承压明显 看好外海收入增长","url":"https://stock-news.laohu8.com/highlight/detail?id=2485045515","media":"华安证券","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2485045515?lang=zh_cn&edition=full","pubTime":"2024-11-21 00:00","pubTimestamp":1732118400,"startTime":"0","endTime":"0","summary":"事件:2024 年10 月30 日,公司发布2024 年第三季度报告。点评:覆膜支架受调价影响,国内市场24H2 承压明显公司单三季度实现营业收入1.82 亿元,同比下滑31.65%,主要系受到政策影响。投资建议:维持“买入”评级我们预计公司2024-2026 年营业收入有望分别实现12.47/13.54/15.99 亿元,同比增长5.1%/8.5%/18.1%;归母净利润分别实现4.89/5.47/6.26 亿元,同比增长-0.7%/11.8%/14.5%;对应EPS 为3.97/4.44/5.08 元;对应PE 倍数为27/25/21x。公司为国内血管介入器械的领军企业,维持“买入”评级。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024112116112595be4e19&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024112116112595be4e19&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688016","BK0251"],"gpt_icon":0},{"id":"2483841663","title":"心脉医疗11月14日遭主力抛售6658万元 环比增加256.81%","url":"https://stock-news.laohu8.com/highlight/detail?id=2483841663","media":"市场透视","labels":["Shareholding Changes"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483841663?lang=zh_cn&edition=full","pubTime":"2024-11-14 15:21","pubTimestamp":1731568873,"startTime":"0","endTime":"0","summary":"11月14日, 心脉医疗股价跌4.74%,报收105.20元,成交金额4.04亿元,换手率3.07%,振幅5.22%,量比0.83。心脉医疗今日主力资金净流出6658万元,上一交易日主力净流出1866万元,今日环比增加256.81%。该股近5个交易日上涨1.12%,主力资金累计净流出4795万元;近20日主力资金累计净流出1.62亿元,其中净流出天数为10日。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241114154640a2369bd2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241114154640a2369bd2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"Shareholding Changes","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0251","688016"],"gpt_icon":0},{"id":"2483178898","title":"心脉医疗大跌5.01% 4家券商给予增持建议","url":"https://stock-news.laohu8.com/highlight/detail?id=2483178898","media":"智选洞察","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483178898?lang=zh_cn&edition=full","pubTime":"2024-11-14 14:37","pubTimestamp":1731566222,"startTime":"0","endTime":"0","summary":"11月14日,心脉医疗股价大幅下跌,截至14点37分,心脉医疗下跌5.01%,报104.91元/股,成交3.65亿元,换手率2.77%。此外,数据统计显示,近半年内4家券商给予增持建议,11家券商给予买入建议。最新财报显示,今年三季报,心脉医疗实现营业收入9.70亿元,同比增长9.13%,净利润为5.53亿元,同比增长42.46%,基本每股收益为4.49元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241114143914abbfe6d4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241114143914abbfe6d4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0251","688016"],"gpt_icon":0},{"id":"2482721284","title":"心脉医疗11月12日获主力加仓4607万元 环比增加695.68%","url":"https://stock-news.laohu8.com/highlight/detail?id=2482721284","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2482721284?lang=zh_cn&edition=full","pubTime":"2024-11-12 15:22","pubTimestamp":1731396123,"startTime":"0","endTime":"0","summary":"11月12日, 心脉医疗股价涨3.87%,报收111.69元,成交金额7.86亿元,换手率5.68%,振幅8.26%,量比1.78。心脉医疗今日主力资金净流入4607万元,上一交易日主力净流入579万元,今日环比增加695.68%。该股近5个交易日上涨10.79%,主力资金累计净流入3972万元;近20日主力资金累计净流出1.46亿元,其中净流出天数为10日。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241112155608a22f8e5e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241112155608a22f8e5e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0251","688016"],"gpt_icon":0},{"id":"2482145547","title":"港股异动 | 微创医疗(00853)盘中涨近8% 心脉医疗前三季度纯利增超42% 小摩上调公司长期净利润率预测","url":"https://stock-news.laohu8.com/highlight/detail?id=2482145547","media":"智通财经","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2482145547?lang=zh_cn&edition=full","pubTime":"2024-11-12 11:41","pubTimestamp":1731382869,"startTime":"0","endTime":"0","summary":"智通财经APP获悉,微创医疗盘中涨近8%,截至发稿,涨4.1%,报6.86港元,成交额9627.74万港元。消息面上,微创医疗公布心脉医疗科技2024年前9个月业绩,收入约9.7亿元,同比增长9.13%;归属于心脉医疗科技股权持有人的净利润约5.53亿元,同比增长42.46%。不过,该行指心脉医疗改善营运效率方面的努力将有助长期利润率,将长期净利润率预测由23%大幅上调至约30%。因此,该行亦相应上调微创医疗长期净利润率预测,由原先11%向上修订至12%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1209673.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["688016","00853"],"gpt_icon":0},{"id":"2482249428","title":"小摩:予微创医疗“增持”评级 目标价升至7.8港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2482249428","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2482249428?lang=zh_cn&edition=full","pubTime":"2024-11-11 10:54","pubTimestamp":1731293646,"startTime":"0","endTime":"0","summary":"小摩发布研究报告称,在微创医疗(00853)附属心脉医疗(688016.SH)公布第三季业绩发表后,将母企微创医疗H股目标价由7.5港元升至7.8港元,评级“增持”。主动脉支架业务部门的胸腔/腹腔主动脉 ...","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://stock.10jqka.com.cn/hks/20241111/c663388944.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tonghuashun","symbols":["688016","BK0251"],"gpt_icon":0},{"id":"2481146903","title":"XD心脉医11月08日遭主力抛售1458万元 环比增加3213.64%","url":"https://stock-news.laohu8.com/highlight/detail?id=2481146903","media":"市场透视","labels":["Shareholding Changes"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481146903?lang=zh_cn&edition=full","pubTime":"2024-11-08 15:18","pubTimestamp":1731050337,"startTime":"0","endTime":"0","summary":"11月08日, XD心脉医股价跌0.47%,报收103.54元,成交金额3.87亿元,换手率3.00%,振幅3.09%,量比1.03。XD心脉医今日主力资金净流出1458万元,上一交易日主力净流出44万元,今日环比增加3213.64%。该股近5个交易日上涨7.40%,主力资金累计净流出504万元;近20日主力资金累计净流出1.75亿元,其中净流出天数为10日。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241108153537a2233a5d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241108153537a2233a5d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"Shareholding Changes","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0251","688016"],"gpt_icon":0},{"id":"2480246378","title":"心脉医疗:累计回购约89万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2480246378","media":"每日经济新闻","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2480246378?lang=zh_cn&edition=full","pubTime":"2024-11-04 16:10","pubTimestamp":1730707800,"startTime":"0","endTime":"0","summary":"截至2024年10月31日,公司通过上海证券交易所交易系统以集中竞价交易方式已累计回购股份约89万股,占公司总股本约1.23亿股的比例为0.73%,回购成交的最高价为98.13元/股,最低价为78.69元/股,支付的资金总额为人民币约7999万元。2023年1至12月份,心脉医疗的营业收入构成为:主动脉及外周血管用产品占比100.0%。截至发稿,心脉医疗市值为122亿元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241104161305ab9daa76&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241104161305ab9daa76&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0251","688016"],"gpt_icon":0},{"id":"2480084930","title":"心脉医疗(688016.SH)2024年半年度权益分派:每股派1.66205元 11月7日股权登记","url":"https://stock-news.laohu8.com/highlight/detail?id=2480084930","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2480084930?lang=zh_cn&edition=full","pubTime":"2024-11-01 18:29","pubTimestamp":1730456956,"startTime":"0","endTime":"0","summary":"智通财经APP讯,心脉医疗(688016.SH)发布2024年半年度权益分派公告,以实施2024年半年度权益分派股权登记日的总股本(扣减回购专用证券账户的股份)为基数,向全体股东每股派发现金红利人民币1.66205元(含税),股权登记日为2024/11/7,除权(息)日为2024/11/8。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1205769.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["688016","BK0251"],"gpt_icon":0},{"id":"2480902138","title":"心脉医疗:降价压力显现 公司调整2024全年预期","url":"https://stock-news.laohu8.com/highlight/detail?id=2480902138","media":"中金公司","labels":["Policy And Regulatory"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2480902138?lang=zh_cn&edition=full","pubTime":"2024-11-01 00:00","pubTimestamp":1730390400,"startTime":"0","endTime":"0","summary":"发展趋势胸主/腹主分别完成降价,公司预计2024 年归母净利润同比增长0-10%。根据公司3 季报,在国家医保局等政府部门指导下1,公司的胸主/腹主动脉覆膜支架在8-9 月分别调整挂网价格,胸主降价40%以上;腹主降价20-35%。根据3 季报,公司将2024 全年归母净利润同比增速预期调整至0-10%。盈利预测与估值考虑胸主/腹主支架降价影响,我们下调2024/25 年归母净利润预测17%/13%至5.34/6.14 亿元,当前股价对应2024/25 年市盈率23/20 倍。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024110114412595bda713&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024110114412595bda713&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"Policy And Regulatory","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0251","688016"],"gpt_icon":1},{"id":"2479767153","title":"心脉医疗(688016)2024年三季报简析:营收净利润同比双双增长","url":"https://stock-news.laohu8.com/highlight/detail?id=2479767153","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2479767153?lang=zh_cn&edition=full","pubTime":"2024-10-31 06:21","pubTimestamp":1730326919,"startTime":"0","endTime":"0","summary":"据证券之星公开数据整理,近期心脉医疗发布2024年三季报。根据财报显示,心脉医疗营收净利润同比双双增长。截至本报告期末,公司营业总收入9.7亿元,同比上升9.13%,归母净利润5.53亿元,同比上升42.46%。按单季度数据看,第三季度营业总收入1.82亿元,同比下降31.65%,第三季度归母净利润1.5亿元,同比上升37.57%。2024年上半年胸主多分支Hector实现了首例海外临床应用。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024103100007831.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688016"],"gpt_icon":0},{"id":"2479294634","title":"心脉医疗大跌5.40% 5家券商给予增持建议","url":"https://stock-news.laohu8.com/highlight/detail?id=2479294634","media":"智选洞察","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2479294634?lang=zh_cn&edition=full","pubTime":"2024-10-30 09:30","pubTimestamp":1730251803,"startTime":"0","endTime":"0","summary":"10月30日,心脉医疗股价大幅下跌,截至09点30分,心脉医疗下跌5.40%,报98.35元/股,成交3235万元,换手率0.27%,振幅0.37%。此外,数据统计显示,近半年内5家券商给予增持建议,11家券商给予买入建议。资金动向截止发稿,心脉医疗获得主力净流出1705万元,其中超大单流出1359万元,大单流出344万元。最新财报显示,今年三季报,心脉医疗实现营业收入9.70亿元,同比增长9.13%,净利润为5.53亿元,同比增长42.46%,基本每股收益为4.49元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241030093041a1f6f3a4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241030093041a1f6f3a4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688016","BK0251"],"gpt_icon":0},{"id":"2479258846","title":"微创医疗(00853.HK)附属心脉医疗科技首九个月赚5.53亿人民币 增长42.5%","url":"https://stock-news.laohu8.com/highlight/detail?id=2479258846","media":"阿斯达克财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2479258846?lang=zh_cn&edition=full","pubTime":"2024-10-30 02:25","pubTimestamp":1730226300,"startTime":"0","endTime":"0","summary":"微创医疗(00853.HK) 公布,附属心脉医疗科技首九个月业绩,实现收入9.7亿人民币(下同),按年增加9.1%。归属股东净利润5.53亿元,增长42.5%。(de/d)(港股报价延迟最少十五分钟。沽空资料截至 2024-10-29 16:25。)过往派息公布日期派息事项派息内容2024/08/30中期业绩无派息2024/03/28末期业绩无派息2023/08/30中期业绩无派息2023/05/18特别报告优先发售:保证配额以优先发售微创心律管理有限公司股份AASTOCKS新闻","market":"hk","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20180321104207082_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20180321104207082_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1392146/latest-news/AAFN","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["00853","BK1585","BK1100","688016","BK1583","BK1589","BK0251"],"gpt_icon":0},{"id":"2479232110","title":"图解心脉医疗三季报:第三季度单季净利润同比增37.57%","url":"https://stock-news.laohu8.com/highlight/detail?id=2479232110","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2479232110?lang=zh_cn&edition=full","pubTime":"2024-10-30 01:38","pubTimestamp":1730223528,"startTime":"0","endTime":"0","summary":"证券之星消息,心脉医疗2024年三季报显示,公司主营收入9.7亿元,同比上升9.13%;归母净利润5.53亿元,同比上升42.46%;扣非净利润5.02亿元,同比上升37.37%;其中2024年第三季度,公司单季度主营收入1.82亿元,同比下降31.65%;单季度归母净利润1.5亿元,同比上升37.57%;单季度扣非净利润1.15亿元,同比上升9.56%;负债率13.99%,投资收益7957.89万元,财务费用-1205.14万元,毛利率75.5%。财报数据概要请见下图:以上内容为证券之星据公开信息整理,由智能算法生成,不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024103000001162.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688016"],"gpt_icon":0},{"id":"2479075494","title":"微创医疗:心脉医疗科技前三季归母净利约5.53亿元,同比增长42.46%","url":"https://stock-news.laohu8.com/highlight/detail?id=2479075494","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2479075494?lang=zh_cn&edition=full","pubTime":"2024-10-29 21:06","pubTimestamp":1730207211,"startTime":"0","endTime":"0","summary":"微创医疗(00853)公布心脉医疗科技2024年前9个月业绩,收入约9.7亿元,同比增长9.13%;归属于心脉医疗科技股权持有人的净利润约5.53亿元,同比增长42.46%。 ...","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://stock.10jqka.com.cn/hks/20241029/c662948073.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tonghuashun","symbols":["688016","BK0251"],"gpt_icon":0},{"id":"2479640748","title":"微创医疗(00853):心脉医疗科技前三季归母净利约5.53亿元,同比增长42.46%","url":"https://stock-news.laohu8.com/highlight/detail?id=2479640748","media":"智通财经网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2479640748?lang=zh_cn&edition=full","pubTime":"2024-10-29 21:04","pubTimestamp":1730207078,"startTime":"0","endTime":"0","summary":"智通财经APP讯,微创医疗(00853)公布心脉医疗科技2024年前9个月业绩,收入约9.7亿元,同比增长9.13%;归属于心脉医疗科技股权持有人的净利润约5.53亿元,同比增长42.46%。更多港股重磅资讯,下载智通财经app更多港股及海外理财资讯,请点击www.zhitongcaijing.com(搜索“智通财经”);欲加入智通港股投资群,请加智通客服微信(ztcjkf)","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1202886.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_zhitongcaijin","symbols":["BK1100","BK1589","00853","BK1583","BK0251","BK1585","688016"],"gpt_icon":0},{"id":"2478676758","title":"心脉医疗10月25日收涨0.93% 主力资金逆市抛售","url":"https://stock-news.laohu8.com/highlight/detail?id=2478676758","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2478676758?lang=zh_cn&edition=full","pubTime":"2024-10-25 15:18","pubTimestamp":1729840710,"startTime":"0","endTime":"0","summary":"10月25日, 心脉医疗股价涨0.93%,报收106.91元,成交金额3.72亿元,换手率2.87%,振幅4.55%,量比0.85。心脉医疗今日主力资金净流出3504万元,上一交易日主力净流入4429万元。该股近5个交易日上涨4.50%,主力资金累计净流入4527万元;近20日主力资金累计净流入2.04亿元,其中净流入天数为13日。该股主力净额占比0.27%,A股市场排名4820/5000,低于行业平均值。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241025152909ab72bc20&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241025152909ab72bc20&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0251","688016"],"gpt_icon":0}],"profile":{"ret":0,"listingDate":"2019-07-22","address":"上海市浦东新区康新公路3399弄1号","stockEarnings":[{"period":"1week","weight":-0.011},{"period":"1month","weight":-0.0078},{"period":"3month","weight":0.2849},{"period":"6month","weight":-0.0785},{"period":"1year","weight":-0.1889},{"period":"ytd","weight":-0.1901}],"companyName":"上海微创心脉医疗科技(集团)股份有限公司","boardCode":"AI0035","perCapita":"7634股","boardName":"专用设备制造业","registeredCapital":"12326万元","compareEarnings":[{"period":"1week","weight":-0.0191},{"period":"1month","weight":-0.0108},{"period":"3month","weight":0.1446},{"period":"6month","weight":0.0577},{"period":"1year","weight":0.0671},{"period":"ytd","weight":0.0982}],"survey":" 上海微创心脉医疗科技(集团)股份有限公司主要从事主动脉及外周血管介入医疗器械的研发、生产和销售。主要产品为胸主动脉覆膜支架系统、腹主动脉覆膜支架系统、术中支架类、球囊类、支架类。公司自成立以来,一直深耕于主动脉及外周血管介入医疗器械领域,通过多年的经验积累,公司已发展成我国主动脉血管介入医疗器械的龙头企业。公司产品已进入全国约1900家医院,主动脉产品国内市场占有率已连续多年排名国产品牌第一。","serverTime":1732305357680,"listedPrice":46.23,"stockholders":"16145人(较上一季度增加10.30%)","compareStock":{"symbol":"000001.SH","name":"上证指数"}},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.2","shortVersion":"4.29.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"心脉医疗(688016)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供心脉医疗(688016)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"心脉医疗,688016,心脉医疗股票,心脉医疗股票老虎,心脉医疗股票老虎国际,心脉医疗行情,心脉医疗股票行情,心脉医疗股价,心脉医疗股市,心脉医疗股票价格,心脉医疗股票交易,心脉医疗股票购买,心脉医疗股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"心脉医疗(688016)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供心脉医疗(688016)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}